Inflammx Therapeutics

Tampa, United States

Inflammx Therapeutics is a biotechnology startup company.

$5.8M raised

Jan 2025

Series A

Biotechnology Health Care Therapeutics

Top Investors

Uniservices

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Inflammx Therapeutics

How much funding has Inflammx Therapeutics raised?

Inflammx Therapeutics has raised $5.8M in total funding. The most recent round was Series A. The last funding was announced in January 2025.

Who are Inflammx Therapeutics's investors?

Inflammx Therapeutics's investors include Uniservices.

Where is Inflammx Therapeutics headquartered?

Inflammx Therapeutics is headquartered in Tampa, United States.

What does Inflammx Therapeutics do?

Inflammx Therapeutics is a biotechnology startup company.

What stage is Inflammx Therapeutics at?

Inflammx Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 10, 2025.

MLA

"Inflammx Therapeutics — Funding & Investors." VCBacked, January 10, 2025, https://www.vcbacked.co/company/inflammx-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2025). Inflammx Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/inflammx-therapeutics

Wikipedia (cite web)

{{cite web |title=Inflammx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inflammx-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 10, 2025.